• No results found

PSA screening

Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening

Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening

... of screening prior to their physician ordering a PSA test; 23 24 have not been asked about their screening preferences prior to a PSA screen- ing test; 25 and some doctors screen without a ...

8

Cost implications of PSA screening differ by age

Cost implications of PSA screening differ by age

... with screening and subse- quent diagnosis, treatment, and complications using reimbursement claims data from a large, self-insured health plan in the mid-Atlantic ...of PSA screening, prostate ...

8

Comment on the Canadian Task Force on the Preventive Health Care on PSA Screening

Comment on the Canadian Task Force on the Preventive Health Care on PSA Screening

... that PSA screening reduces overall mortality among men of any age; (b) conflicting evidence suggesting a small and uncertain potential reduction in prostate cancer mortality among men aged 55–69 years; (c) ...

5

Exploring patient perceptions of PSA screening for prostate cancer

Exploring patient perceptions of PSA screening for prostate cancer

... potential screening age category defined in the ERSPC had a high self-reported rate of PSA screening (66% in the past 2 years), believed that the PSA test was not associated with any risk ...

6

PSA Screening for Prostate Cancer in Men under the Age of 65: A Review of Current Practice

PSA Screening for Prostate Cancer in Men under the Age of 65: A Review of Current Practice

... of PSA testing for Ade- nocarcinoma of the Prostate, specifically in men under age 65, and those liv- ing with risk factors for the ...of PSA testing in various age groups was conducted with the goal being ...

26

A Community Jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening—a qualitative analysis

A Community Jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening—a qualitative analysis

... of PSA screening make this dif fi cult to achieve within the context of the average clinical consultation and can be burdensome for patients and ...on PSA testing emphasise the provision of ...

8

The relationship between Agent Orange and prostate specific antigen: a comparison of a hotspot and a non-sprayed area in Vietnam

The relationship between Agent Orange and prostate specific antigen: a comparison of a hotspot and a non-sprayed area in Vietnam

... Hand, PSA screening was used to detect prostate cancer in Vietnam veterans over the period 1999–2003 ...of PSA are found in semen, some PSA escapes the prostate and can be found in the ...

5

Understanding the PSA test

Understanding the PSA test

... prostate screening. It is not known for sure if screening can reduce the number of deaths from prostate ...of PSA screening have been carried ...

19

Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?

Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?

... drive PSA screening, where men identify concerns about cancer, the need for peace of mind and control over one’s health as reasons for undergoing PSA testing [14, ...undergo PSA testing, and ...

8

Use of prostate-specific antigen testing in Medicare beneficiaries

Use of prostate-specific antigen testing in Medicare beneficiaries

... received PSA testing in the past. Whereas the rates of PSA testing declined over time among previously unscreened men, screening frequency remained more constant among men with evidence of prior ...

10

Simulation Optimization of Prostate Cancer Screening Using a Parallel Genetic Algorithm.

Simulation Optimization of Prostate Cancer Screening Using a Parallel Genetic Algorithm.

... To enhance the perspective on optimization of PSA-threshold screening, costs may be incorpo- rated into this model, as in [47]. Providing a cost-effectiveness analysis would further inform the debate on ...

68

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study

... prostate screening guidelines recommend that all men over age 50 who have a life expectancy of at least 10 years should have an annual digital examination and PSA ...ongoing screening trials show ...

8

Risk-Based Simulation Optimization of PSA-Based Prostate Cancer Screening

Risk-Based Simulation Optimization of PSA-Based Prostate Cancer Screening

... patient’s PSA value increases by a percentage (plus a small random error) that depends on the patient’s cancer stage and stage ...different screening strategies on the basis of benefits harms, specifically, ...

250

Who and when should we screen for prostate cancer? Interviews with key opinion leaders

Who and when should we screen for prostate cancer? Interviews with key opinion leaders

... M Barry & D Frosch: It is important to recognize that providing decision aids to patients does not in itself con- stitute shared decision-making. Rather, these tools are intended to support a shared deliberative ...

17

Burden of PSA testing

Burden of PSA testing

... vs PSA tested, thus enabling the investigation into the effects of PSA testing on men’s ...between PSA tested (screened) men and those presenting symptomatically, we excluded men where the PSA ...

46

Role of Prostate Volume in the Early Detection of Prostate Cancer in a Cohort with Slowly Increasing Prostate Specific Antigen

Role of Prostate Volume in the Early Detection of Prostate Cancer in a Cohort with Slowly Increasing Prostate Specific Antigen

... serum PSA lev- els more than two times between January 2001 and No- vember 2011 were the subjects of this ...elevated PSA level due to chronic prostati- tis or with a history of 5-α-reductase use for benign ...

5

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?

... of Psa, particularly in the range lower 10 ng/ml, is the measurement of molecular isoforms of ...free Psa (fPsa) and the complexed Psa (cPsa) bound to ...the Psa range of lower 10 ng/ml, for ...

6

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer

... The characteristics of the patients are shown in Table 1. The median age and PSA at diagnosis were 73 years (range 50 to 92) and 174 ng/mL (range 5.7 to 21864), re- spectively. The median follow-up was 47 months ...

6

Sentencing Principles in the High Court and the PSA

Sentencing Principles in the High Court and the PSA

... Queensland PSA. Section 13(2) of the PSA focuses on the time when a guilty plea is made or ...the PSA, it would seem that this principle should be applied to the interpretation of s ...the PSA ...

18

Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments

Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments

... for PSA, so that as virally infected cells are exposed to immune processing and attack, PSA will be treated as a viral protein for rejection, rather than a self-antigen leading to usual, but pathologic, ...

18

Show all 10000 documents...

Related subjects